08:41 AM EDT, 06/06/2024 (MT Newswires) -- GSK (GSK) said Thursday it has completed its acquisition Elsie Biotechnologies for up to $50 million.

The acquisition will enhance GSK's research and development capabilities with Elsie's portfolio in oligonucleotide therapeutics, an alternative to traditional biologics.

Price: 42.05, Change: +0.08, Percent Change: +0.19